Escamilla-Ríos DE

Language: Spanish
References: 22
Page: 226-229
PDF size: 70.85 Kb.

Text Extraction

No abstract

REFERENCES

1. Bryson EO, Silverstein J. Addiction and Substance Abuse in Anesthesiology, Anesthesiology 2008;109(5):905-17.

2. Kintz P, Villain M, Dumestre V, Cririmele V. Evidence of addiction by anesthesiologist as documented by hair analysis. Forensic Sci Int 2005; 153:81-84.

3. Gold MS, Byars JA, Frost-Pineda K. Occupational exposure and addiction for physicians: case studies and theoretical implications. Psychiatr Clin North Am 2004;27:745-753.

4. Raymond CR, Chapter 96. Substance Dependence and Abuse in Anesthesia Care Providers in Anesthesiology, Ed McGraw Hill:US; 2008.

5. Silvertesin JH, Silva DA, Iberti TJ Opioid Addiction in Anesthesiology, Anesthesiology. 1993;79(2):354-75.

6. Fitzsimons MG, Baker KH. Not all strikes Are Easy to Call, Anesth Analg 2009;109(3):693-4.

7. Sivarajan M, Posner KL, Caplan RA, Gild WM, Cheeney FW: Substance Abuse among anesthesiologists. Anesthesiology 1994;80:704.

8. Covarrubias A, Betancourt José, González José, Adicciones, anestesia y dolor , Rev Mex Anest 2011;34(3):200-10.

9. American Psychiatric Association. Dignostic and statistical manual of mental disorders and text revision: DSM-IV-TR. 4th. Edition. American Psychiatric Association: Washigton DC; 2000.

10. Biebuyk JF. Opioid Addiction in Anesthesiology. Anesthesiology. 1993;79(2):354-75.

11. Lettieri, DJ. Drug Abuse: A review of explanations and models of explanation, Alcohol and Substance abuse in Adolescence. Guest Editions:New York; 1985.

12. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actionsto habits to compusion. Nat Neurosci 2005;8:1481-89.

13. Nestler EJ. Molecular basis of neural plasticity underlaying addiction. Nat Rev Neurosci 2001;2:119-28.

14. Cami J, Ferre M. Mechanisms of disease: Drug addiction. N Engl J Med 2003;349:975-86.

15. Raymond CR. Subtance Dependence and Abuse in Anesthesia Care Providers in Anesthesiology, Longnecker. Ed. Mac Graw Hill: US; 2008.

16. Mohn AR, Yao WD, Caron MG. Genetic and genomic approaches to reward and addiction. Neuropharmacology 2004;47:101-10.

17. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, et al. Association of dopamine trasnporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 2003;160:1699-1701.

18. Malison RT, Best SE, Wallace EA, McCance E, Laruelle M, Zoghbi SS. Euphorigenic doses of cocaine reduce (1231) eta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology 1995;122:358-362.

19. Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB. Reduced Central serotonin transporters in alcoholism. Am J Psychatry 1998; 155:1544-49.

20. Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Pomm R, Frost-Pineda K. Fentanyl abuse and dependence further evidence for second hand exposure hypothesis. J Addict Dis 2006; 25 :15-21

21. Skkiper G, Cambell M, Dupont RL, Anesthesiologists with Substance use Disorders : A 5- year Outcome Study from 16 State Physician Health Programs, Anesth Analg. 2009;109(3):891-6.

22. Fitzsimmons MG, Baker KH, Lowenstein E, Zapol WM. Random drug testing to reduce the incidence of addiction in anesthesia residents: preliminary results from one program. Anesth Analg 2008;107(2):630-5.